WOODLAWN, Md. – The Centers for Medicare & Medicaid Services is reversing its position on reimbursement for smartphone-connected continuous glucose monitors, after hearing from a number of patients and other stakeholders. “CMS heard from numerous stakeholders who shared their concerns that Medicare’s CGM coverage policy limited their use of CGMs in conjunction with their smartphones, preventing them from sharing data with family members, physicians and caregivers,” wrote CMS in a statement. CMS said that Medicare’s published coverage policy for CGMs will be modified to support the use of CGMs in conjunction with a smartphone, including data sharing. “These changes are consistent with the Agency’s approach of putting patients first and incentivizing innovation and use of e-technology,” CMS wrote.
You are here: / / CMS reverses reimbursement policy on smartphone-connected CGMs